Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+


  Stem Cell Research

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 51 articles:
HTML format
Text format



Single Articles


    January 2020
  1. OKUYAMA H, Nogami W, Sato Y, Yoshida H, et al
    Characterization of CD44-positive Cancer Stem-like Cells in COLO 201 Cells.
    Anticancer Res. 2020;40:169-176.
    PubMed     Text format     Abstract available


  2. LI J, Vangundy Z, Poi M
    PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
    Anticancer Res. 2020;40:133-141.
    PubMed     Text format     Abstract available


    December 2019
  3. HAN HR, Park SA, Ahn S, Jeun SS, et al
    Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.
    Anticancer Res. 2019;39:6635-6643.
    PubMed     Text format     Abstract available


  4. TANAKA H, Kawaguchi M, Shoda S, Miyoshi T, et al
    Nuclear Accumulation of beta-Catenin in Cancer Stem Cell Radioresistance and Stemness in Human Colon Cancer.
    Anticancer Res. 2019;39:6575-6583.
    PubMed     Text format     Abstract available


    November 2019
  5. ROMANENKO MV, Dolgova EV, Osipov ID, Ritter GS, et al
    Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.
    Anticancer Res. 2019;39:6073-6086.
    PubMed     Text format     Abstract available


  6. TODA Y, Yoshimura R, Itahara M, Imai Y, et al
    DJ-1 Contributes to Self-renewal of Stem Cells in the U87-MG Glioblastoma Cell Line.
    Anticancer Res. 2019;39:5983-5990.
    PubMed     Text format     Abstract available


    October 2019
  7. ZAIMOKU R, Miyashita T, Tajima H, Takamura H, et al
    Monitoring of Heat Shock Response and Phenotypic Changes in Hepatocellular Carcinoma After Heat Treatment.
    Anticancer Res. 2019;39:5393-5401.
    PubMed     Text format     Abstract available


    September 2019
  8. INTUYOD K, Hahnvajanawong C, Pinlaor P, Pinlaor S, et al
    Anti-parasitic Drug Ivermectin Exhibits Potent Anticancer Activity Against Gemcitabine-resistant Cholangiocarcinoma In Vitro.
    Anticancer Res. 2019;39:4837-4843.
    PubMed     Text format     Abstract available


  9. SANOMACHI T, Suzuki S, Togashi K, Seino S, et al
    Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer.
    Anticancer Res. 2019;39:4817-4828.
    PubMed     Text format     Abstract available


  10. GE H, Cheng N, Xu X, Yang Z, et al
    AMMECR1 Inhibits Apoptosis and Promotes Cell-cycle Progression and Proliferation of the A549 Human Lung Cancer Cell Line.
    Anticancer Res. 2019;39:4637-4642.
    PubMed     Text format     Abstract available


    August 2019
  11. SINHA AA
    Electron Microscopic Analysis of Stem Cells in Human Prostate Cancer, Including Inverted Capsule Embedding Methods for Archival Sections and Falcon Films for Prostate Cancer Cell Lines.
    Anticancer Res. 2019;39:4171-4177.
    PubMed     Text format     Abstract available


    June 2019
  12. GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
    The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Anticancer Res. 2019;39:2689-2697.
    PubMed     Text format     Abstract available


    April 2019
  13. ISHIBASHI N, Maebayashi T, Sakaguchi M, Aizawa T, et al
    Myelosuppression After Radiation Therapy in Patients With and Without Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Observational Study.
    Anticancer Res. 2019;39:2163-2167.
    PubMed     Text format     Abstract available


  14. MASTER S, Koshy N, Mansour R, Shi R, et al
    Effect of Stem Cell Transplant on Survival in Adult Patients With Acute Lymphoblastic Leukemia: NCDB Analysis.
    Anticancer Res. 2019;39:1899-1906.
    PubMed     Text format     Abstract available


  15. OSMAN J, Bellamkonda K, Liu Q, Andersson T, et al
    The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer.
    Anticancer Res. 2019;39:1719-1728.
    PubMed     Text format     Abstract available


    March 2019

  16. Hepatic Stem Cells.
    Anticancer Res. 2019;39:1631.
    PubMed     Text format    


  17. MURAKI Y, Hasegawa T, Takeda D, Ueha T, et al
    Induced Pluripotent Stem Cell-related Genes Correlate With Poor Prognoses of Oral Squamous Cell Carcinoma.
    Anticancer Res. 2019;39:1205-1216.
    PubMed     Text format     Abstract available


  18. VASYUTIN I, Zerihun L, Ivan C, Atala A, et al
    Bladder Organoids and Spheroids: Potential Tools for Normal and Diseased Tissue Modelling.
    Anticancer Res. 2019;39:1105-1118.
    PubMed     Text format     Abstract available


    February 2019
  19. YAMAMOTO M, Suzuki S, Togashi K, Sanomachi T, et al
    AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1.
    Anticancer Res. 2019;39:609-617.
    PubMed     Text format     Abstract available


  20. SAKAMOTO D, Takagi T, Fujita M, Omura S, et al
    Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma.
    Anticancer Res. 2019;39:597-607.
    PubMed     Text format     Abstract available


    January 2019
  21. STELLA S, Massimino M, Tirro E, Vitale SR, et al
    B-ALL Relapses After Autologous Stem Cell Transplantation Associated With a Shift from e1a2 to e14a2 BCR-ABL Transcripts: A Case Report.
    Anticancer Res. 2019;39:431-435.
    PubMed     Text format     Abstract available


  22. NUMAKURA S, Uozaki H, Kikuchi Y, Watabe S, et al
    Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
    Anticancer Res. 2019;39:387-393.
    PubMed     Text format     Abstract available


  23. KIM KH, Cheong HJ, Lee MY, Lee N, et al
    Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
    Anticancer Res. 2019;39:127-133.
    PubMed     Text format     Abstract available


  24. KAWAGUCHI-IHARA N, Zhao Y, Nakamura S, Suzuki K, et al
    Chloroquine Inhibits Self-Renewal of Blast Progenitors Synergistically With Phytochemicals or Nonsteroidal Anti-inflammatory Drugs in Hematological Malignant Cell Lines.
    Anticancer Res. 2019;39:87-98.
    PubMed     Text format     Abstract available


    December 2018
  25. KIM J, Ahn S, Kim K, Cho MS, et al
    Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Anticancer Res. 2018;38:6881-6889.
    PubMed     Text format     Abstract available


  26. YAMAMOTO M, Suzuki S, Togashi K, Sanomachi T, et al
    AS602801, an Anticancer Stem Cell Candidate Drug, Reduces Survivin Expression and Sensitizes A2780 Ovarian Cancer Stem Cells to Carboplatin and Paclitaxel.
    Anticancer Res. 2018;38:6699-6706.
    PubMed     Text format     Abstract available


    November 2018
  27. HEATH EI, Heilbrun LK, Smith D, Schopperle WM, et al
    Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.
    Anticancer Res. 2018;38:6361-6366.
    PubMed     Text format     Abstract available


  28. FU S, Lin J
    Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells.
    Anticancer Res. 2018;38:6271-6279.
    PubMed     Text format     Abstract available


    October 2018
  29. SINHA AA, Wilson MJ
    Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133.
    Anticancer Res. 2018;38:5725-5732.
    PubMed     Text format     Abstract available


    September 2018
  30. KURAMOTO K, Yamamoto M, Suzuki S, Sanomachi T, et al
    AS602801, an Anti-Cancer Stem Cell Drug Candidate, Suppresses Gap-junction Communication Between Lung Cancer Stem Cells and Astrocytes.
    Anticancer Res. 2018;38:5093-5099.
    PubMed     Text format     Abstract available


  31. TRESKA V, Fichtl J, Ludvik J, Bruha J, et al
    Portal Vein Embolization (PVE) Versus PVE with Haematopoietic Stem Cell Application in Patients with Primarily Non-resectable Colorectal Liver Metastases.
    Anticancer Res. 2018;38:5531-5537.
    PubMed     Text format     Abstract available


  32. YANG WH, Cheng CY, Chen MF, Wang TC, et al
    Cell Subpopulations Overexpressing p75NTR Have Tumor-initiating Properties in the C6 Glioma Cell Line.
    Anticancer Res. 2018;38:5183-5192.
    PubMed     Text format     Abstract available


    August 2018
  33. FUNATO M, Ozeki M, Suzuki A, Ishihara M, et al
    Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
    Anticancer Res. 2018;38:4691-4697.
    PubMed     Text format     Abstract available


  34. TOGASHI K, Okada M, Yamamoto M, Suzuki S, et al
    A Small-molecule Kinase Inhibitor, CEP-1347, Inhibits Survivin Expression and Sensitizes Ovarian Cancer Stem Cells to Paclitaxel.
    Anticancer Res. 2018;38:4535-4542.
    PubMed     Text format     Abstract available


    July 2018
  35. CHANDIMALI N, Huynh DL, Jin WY, Kwon T, et al
    Combination Effects of Hispidin and Gemcitabine via Inhibition of Stemness in Pancreatic Cancer Stem Cells.
    Anticancer Res. 2018;38:3967-3975.
    PubMed     Text format     Abstract available


  36. MAIUTHED A, Chantarawong W, Chanvorachote P
    Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
    Anticancer Res. 2018;38:3797-3809.
    PubMed     Text format     Abstract available


    June 2018
  37. KOESSINGER D, Albrecht V, Faber F, Jaehnert I, et al
    ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells.
    Anticancer Res. 2018;38:3347-3355.
    PubMed     Text format     Abstract available


    May 2018
  38. CLOUSTON HW, Rees PA, Lamb R, Duff SE, et al
    Effect of Tissue Factor on Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:2635-2642.
    PubMed     Text format     Abstract available


  39. NASSEREDDINE S, Alsubait S, Tabbara I
    Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
    Anticancer Res. 2018;38:2597-2605.
    PubMed     Text format     Abstract available


  40. KAWAMOTO M, Umebayashi M, Tanaka H, Koya N, et al
    Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
    Anticancer Res. 2018;38:2739-2748.
    PubMed     Text format     Abstract available


    April 2018
  41. TERASAKI M, Ogawa Y, Endo T, Maeda H, et al
    Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
    Anticancer Res. 2018;38:2169-2179.
    PubMed     Text format     Abstract available


  42. SANTORO R, Zanotto M, Carbone C, Piro G, et al
    MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity.
    Anticancer Res. 2018;38:1937-1946.
    PubMed     Text format     Abstract available


    March 2018
  43. KANEKO S, Sato C, Shiozawa N, Sato A, et al
    Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
    Anticancer Res. 2018;38:1391-1399.
    PubMed     Text format     Abstract available


    February 2018
  44. KANG S, Oh SC, Min BW, Lee DH, et al
    Transglutaminase 2 Regulates Self-renewal and Stem Cell Marker of Human Colorectal Cancer Stem Cells.
    Anticancer Res. 2018;38:787-794.
    PubMed     Text format     Abstract available


    January 2018
  45. SPELT L, Sasor A, Ansari D, Hilmersson KS, et al
    The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases.
    Anticancer Res. 2018;38:313-320.
    PubMed     Text format     Abstract available


  46. LAPINSKA K, Faria G, McGonagle S, Macumber KM, et al
    Cancer Progenitor Cells: The Result of an Epigenetic Event?
    Anticancer Res. 2018;38:1-6.
    PubMed     Text format     Abstract available


    November 2017
  47. SANOMACHI T, Suzuki S, Kuramoto K, Takeda H, et al
    Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents.
    Anticancer Res. 2017;37:6177-6188.
    PubMed     Text format     Abstract available


    October 2017
  48. MORINE Y, Imura S, Ikemoto T, Iwahashi S, et al
    CD44 Expression Is a Prognostic Factor in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.
    Anticancer Res. 2017;37:5701-5705.
    PubMed     Text format     Abstract available


  49. NASMAN A, Bersani C, Lindquist D, Du J, et al
    Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
    Anticancer Res. 2017;37:5319-5328.
    PubMed     Text format     Abstract available


    September 2017
  50. JUNGBAUER F, Aderhold C, Birk R, Hoermann K, et al
    Communicate or Die - A Model for HPV+ and HPV- CSCs and Their Interactions with SDF-1alpha.
    Anticancer Res. 2017;37:4827-4836.
    PubMed     Text format     Abstract available


  51. GOMES JPA, Assoni AF, Pelatti M, Coatti G, et al
    Deepening a Simple Question: Can MSCs Be Used to Treat Cancer?
    Anticancer Res. 2017;37:4747-4758.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: